Advertisement
Screener

ENTRADA THERAPEUTICS, INC. (TRDA) Income Taxes Paid

1.4 / 5 stars · 12/42 Roast Me

ENTRADA THERAPEUTICS, INC. Income Taxes Paid

ENTRADA THERAPEUTICS, INC. (TRDA) reported Income Taxes Paid of $1.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26

  • ENTRADA THERAPEUTICS, INC. income taxes paid, net for fiscal 2025 was $1.70M, a 63.24% decline from fiscal 2024.
  • ENTRADA THERAPEUTICS, INC. income taxes paid, net for fiscal 2024 was $4.62M, a 68.59% decline from fiscal 2023.
  • ENTRADA THERAPEUTICS, INC. income taxes paid, net for fiscal 2023 was $14.72M.
  • ENTRADA THERAPEUTICS, INC. income taxes paid, net for fiscal 2022 was $0.00.
Period endIncome Taxes Paid, Net 12 month
2025-12-31$1.70M
10-K · filed 2026-02-26
2024-12-31$4.62M
10-K · filed 2026-02-26
2023-12-31$14.72M
10-K · filed 2025-02-27
2022-12-31$0.00
10-K · filed 2024-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55